Janus Henderson Group PLC Entrada Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,549,497 shares of TRDA stock, worth $30.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,549,497Holding current value
$30.7 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TRDA
# of Institutions
93Shares Held
27.9MCall Options Held
100Put Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$96.3 Million0.92% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$87.6 Million34.63% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$87.2 Million29.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.13MShares$62 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$33.5 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $621M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...